関連する実験動画
Updated: Aug 15, 2026

08:04
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
Published on: December 20, 2017
OKT3モノクローナル抗体に対するヒトの免疫応答はオリゴクローナルである
まとめ
ミューリンのモノクローナル抗体OKT3は,移植における免疫抑制に使用されますが,抗体反応を引き起こします. この反応はオリゴクローナルであり,同一の特異性を持つ異なる抗体の連続使用が,感受性を克服することを示唆しています.
科学分野:
- 免疫学 免疫学とは
- 移植医療 移植医療について
- バイオテクノロジー バイオテクノロジー
背景:
- OKT3のようなモノクローナル抗体は,臨床移植における免疫抑制に不可欠である.
- OKT3は,成熟したヒトTリンパ球の複合体を標的とし,T細胞受容体と結びついています.
- ネズミのモノクローン抗体の治療的使用は,患者の抗体反応によって制限され,有効性が低下します.
研究 の 目的:
- OKT3.3に対する抗体反応の性質を調査する.
- モノクローナル抗体に対する免疫感受性を克服するための戦略を in vivo で探求する.
主な方法:
- 抗体生成のためにハイブリドトーム技術を活用した.
- OKT3.3に対する抗体反応を分析するために,アイソエレクトロフォーカシングを使用した.
主要な成果:
- OKT3に対する抗体の反応は,特異性 (対同型および対異型) が制限されていることが確認されました.
- アイソエレクトロフォーカシングにより,抗OKT3抗体反応はオリゴクローナルであることが明らかになった.
- このオリゴクローナルの性質は,免疫応答の幅の潜在的な制限を示唆しています.
結論:
- OKT3に対する免疫応答は,ポリクローンではなく,オリゴクローンである.
- 共通の特異性を持つ異なったモノクローナル抗体を連続して投与すると,感受性を回避することがあります.
- この戦略は,モノクローナル抗体ベースの免疫抑制の治療効果を延ばす可能性がある.
関連する概念動画
Humoral Immune Responses
Overview
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

